PRESS RELEASE published on 09/29/2025 at 10:34, 10 months 13 days ago Genmab to Acquire HBM Portfolio Company Merus for USD 8 billion in Cash Genmab to acquire HBM portfolio company Merus for USD 8 billion in cash. Merus is known for its innovative oncology therapies. The transaction with Genmab represents a 41% premium on the closing price Acquisition Oncology HBM Healthcare Genmab Merus
BRIEF published on 09/16/2025 at 17:52, 10 months 26 days ago HBM Healthcare Investments AG Reports Modest Growth in September 2025 Financial Results Net Asset Value Investment Performance Share Price HBM Healthcare
BRIEF published on 09/16/2025 at 17:52, 10 months 26 days ago HBM Healthcare Investments AG annonce une croissance modeste en septembre 2025 Résultats Financiers Cours De L'action Performance Des Investissements HBM Santé Valeur Nette D'inventaire
PRESS RELEASE published on 09/16/2025 at 17:47, 10 months 26 days ago Key Figures 15.09.2025 HBM Healthcare Investments AG reports key figures for 15.09.2025 in CHF. NAV at 245.43, Share Price at 178.00, and Total Net Assets at 1,641 million. Performance percentages shown Performance HBM Healthcare Investments AG Key Figures CHF 15.09.2025
BRIEF published on 09/10/2025 at 08:40, 11 months 2 days ago Swixx BioPharma and Lundbeck Forge Multi-Regional CNS Partnership Emerging Markets Swixx BioPharma Healthcare Investments Lundbeck CNS Partnership
BRIEF published on 09/10/2025 at 08:40, 11 months 2 days ago Swixx BioPharma et Lundbeck forment un partenariat multirégional pour le SNC Marchés Émergents Swixx BioPharma Investissements Dans Les Soins De Santé Lundbeck Partenariat CNS
PRESS RELEASE published on 09/10/2025 at 08:35, 11 months 2 days ago HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Partnership HBM Healthcare Investments announces partnership between Swixx BioPharma, Lundbeck for CNS therapies in South-East Europe, Turkey and Latin America Partnership HBM Healthcare Investments CNS Therapies Swixx BioPharma Lundbeck
BRIEF published on 09/01/2025 at 17:52, 11 months 11 days ago HBM Healthcare Investments AG Reports August 2025 Key Figures Performance Share Price NAV Swiss Exchange HBM Healthcare
BRIEF published on 09/01/2025 at 17:52, 11 months 11 days ago HBM Healthcare Investments AG publie ses chiffres clés d'août 2025 Performance NAV Cours De L'action Bourse Suisse HBM Santé
PRESS RELEASE published on 09/01/2025 at 17:47, 11 months 11 days ago Key Figures 31.08.2025 HBM Healthcare Investments AG reports key financial figures for August 2025, with a NAV of 240.62 CHF and Total Net Assets of 1,610 million CHF. Share price increased by 4.0% HBM Healthcare Investments Financial Figures Share Price NAV August 2025
Published on 08/12/2026 at 15:42, 3 hours 54 minutes ago Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 3 hours 54 minutes ago Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 4 hours 36 minutes ago Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 4 hours 51 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 18:17, 1 hour 19 minutes ago EQS-Adhoc: Gateway Real Estate AG resolves segment change from the regulated market (Prime Standard) to the Scale segment of the open market (Freiverkehr) on the Frankfurt Stock Exchange
Published on 08/12/2026 at 18:15, 1 hour 21 minutes ago Shelly Group Delivers Strong Revenue and Earnings Growth in the First Six Months of 2026
Published on 08/11/2026 at 17:45, 1 day 1 hour ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 1 hour ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
